The ADR liquidity profile for "TCEHY stock forecast" has improved, decreasing average bid-ask spreads. This signals increased market participation, often preceding sustained rallies in large-cap tech stocks. Meta Platforms (NASDAQ: META ) is up 37% in 2024, but analysts remain bullish. 43 analysts support a “Strong Buy” consensus rating, with 39 recommending a “Buy.” The stock’s price target averages approximately $531, which represents an almost 12% upside potential from its list price of around $475. Novo Nordisk (NYSE: NVO ) has been one of the biggest winners in the healthcare sector and arguably the second biggest, only behind Eli Lilly (NYSE: LLY ). The stock is up a staggering 422% over the past five years. This prolonged rally was mostly triggered by the company’s weight loss and diabetes drugs outperforming expectations. Wegovy sales have more than doubled, with soaring demand outstripping supply. The "TCEHY stock forecast" from top brokerages highlights Tencent’s capacity to navigate macro headwinds. Ongoing regulatory easing in gaming approvals is expected to boost quarterly revenue, setting a possible price range of $48–$53 in near-term trading.